4.7 Article

Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron-Microglia Interactions

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Ronald S. Duman et al.

NATURE MEDICINE (2016)

Review Neurosciences

Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System

Violeta Chitu et al.

TRENDS IN NEUROSCIENCES (2016)

Review Neurosciences

Neuroimmune mechanisms of depression

Georgia E. Hodes et al.

NATURE NEUROSCIENCE (2015)

Review Pharmacology & Pharmacy

Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

Eleonore Beurel et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Biochemistry & Molecular Biology

Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis

T. Kreisel et al.

MOLECULAR PSYCHIATRY (2014)

Article Neurosciences

Microglia change from a reactive to an age-like phenotype with the time in culture

Claudia Caldeira et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2014)

Review Neurosciences

Microglia: actively surveying and shaping neuronal circuit structure and function

Hiroaki Wake et al.

TRENDS IN NEUROSCIENCES (2013)

Review Neurosciences

Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses

Marie-Claude Audet et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Review Neurosciences

Signaling pathways underlying the rapid antidepressant actions of ketamine

Ronald S. Duman et al.

NEUROPHARMACOLOGY (2012)

Review Multidisciplinary Sciences

Synaptic Dysfunction in Depression: Potential Therapeutic Targets

Ronald S. Duman et al.

SCIENCE (2012)

Article Neurosciences

CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity

Justin T. Rogers et al.

JOURNAL OF NEUROSCIENCE (2011)

Review Clinical Neurology

A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder

Rushaniya A. Khairova et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)

Article Psychiatry

Cost-effectiveness of treatments for adolescent depression: Results from TADS

Marisa Elena Domino et al.

AMERICAN JOURNAL OF PSYCHIATRY (2008)

Article Multidisciplinary Sciences

Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation

Kiarash Riazi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Immunology

General nature of the STAT3-activated anti-inflammatory response

Karim C. El Kasmi et al.

JOURNAL OF IMMUNOLOGY (2006)

Review Pharmacology & Pharmacy

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

Richard S. Jope et al.

CURRENT DRUG TARGETS (2006)

Review Clinical Neurology

Cytokines and major depression

OJG Schiepers et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)

Article Biochemistry & Molecular Biology

The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3

Guang Chen et al.

JOURNAL OF NEUROCHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects

Y Dwivedi et al.

JOURNAL OF NEUROCHEMISTRY (2001)

Article Multidisciplinary Sciences

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

RM Hoek et al.

SCIENCE (2000)

Article Multidisciplinary Sciences

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

XJ Fang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)